CliniExperts is supported by a group of powerful Key Opinion Leaders on the advisory board and has over 12 years of expertise. These KOLs are clinical doctors with extensive experience in their chosen therapeutic specialties who are well-known, highly respected, and trusted.
Our advisory panel comprises of clinicians that have been co-investigators or principal investigators in observational as well as multi-centre phase III multi-drug trials. These opinion leaders provide us their invaluable advice and astute guidance on drug development, clinical research, and regulatory compliance. Their inputs on protocol design, primary and secondary endpoints, primary and secondary objectives, inclusion and exclusion criteria, and formulation of the clinical investigation plans are second to none.